Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H7O2S.Tc.3HO.H2O |
| Molecular Weight | 287.106 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O.[OH-].[OH-].[OH-].[99Tc+4].CC(C)(S)C([O-])=O
InChI
InChIKey=ODSQWERRZUPMRV-PUQAOBSFSA-J
InChI=1S/C4H8O2S.4H2O.Tc/c1-4(2,7)3(5)6;;;;;/h7H,1-2H3,(H,5,6);4*1H2;/q;;;;;+4/p-4/i;;;;;1+1
| Molecular Formula | C4H7O2S |
| Molecular Weight | 119.162 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | HO |
| Molecular Weight | 17.0073 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Tc |
| Molecular Weight | 98.9063 |
| Charge | 4 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | OSTEOLITE Approved UseUnknown Launch Date1977 |
|||
| Diagnostic | DRAXIMAGE MDP-10 Approved UseMDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date1978 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:44 GMT 2023
by
admin
on
Fri Dec 15 15:16:44 GMT 2023
|
| Record UNII |
ZMI2B41JDH
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ZMI2B41JDH
Created by
admin on Fri Dec 15 15:16:44 GMT 2023 , Edited by admin on Fri Dec 15 15:16:44 GMT 2023
|
PRIMARY | |||
|
145996660
Created by
admin on Fri Dec 15 15:16:44 GMT 2023 , Edited by admin on Fri Dec 15 15:16:44 GMT 2023
|
PRIMARY | |||
|
75818-16-5
Created by
admin on Fri Dec 15 15:16:44 GMT 2023 , Edited by admin on Fri Dec 15 15:16:44 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
